Zimmer Biomet Holdings (ZBH) Receivables (2009 - 2026)

Zimmer Biomet Holdings has reported Receivables for 18 years, with the latest figure at $1.7 billion in Q1 2026.

• For the quarter ending Q1 2026, Receivables rose 12.73% year-over-year to $1.7 billion; the trailing twelve-month figure through Mar 2026 stood at $1.7 billion (up 12.73% YoY), and the FY2025 full-year result was $1.7 billion, up 15.11% from the prior year.
• Receivables for Q1 2026 stood at $1.7 billion, up from $1.7 billion in the prior quarter.
• The five-year high for Receivables was $1.7 billion in Q1 2026, with the low at $1.3 billion in Q1 2022.
• Average Receivables over 5 years is $1.5 billion, with a median of $1.4 billion recorded in 2023.
• Year-over-year, Receivables decreased 9.74% in 2022 and climbed 15.11% in 2025.
• Tracing ZBH's Receivables over 5 years: stood at $1.4 billion in 2022, then grew by 4.41% to $1.4 billion in 2023, then gained by 2.66% to $1.5 billion in 2024, then rose by 15.11% to $1.7 billion in 2025, then rose by 1.42% to $1.7 billion in 2026.
• The last three Receivables figures came in at $1.7 billion (Q1 2026), $1.7 billion (Q4 2025), and $1.6 billion (Q3 2025), per Business Quant data.

Peer Comparison